Press and Media


RMDM Group is a UK-based one-stop-shop for cancer diagnostics, prevention and treatment. We use ground-breaking technology to provide healthcare partners worldwide with non-invasive, low cost and highly accurate early intervention diagnostic tools.

Business Overview

Established in 2017, RMDM is founded on the principles of the pioneering work of Dr Johannes Coy, who discovered the TKTL1 gene. Our purpose is to harness the power of cutting-edge research and technology to provide practical and affordable interventions to support health and wellbeing, focusing particularly on diagnostics and metabolism. The revolutionary PanTum Detect test is one such example.

Through our commitment to rigorous research and scientific collaboration, we work to translate evidence into practice in a way that positively disrupts the health and wellbeing industry.


Multimedia

TalkRadio Live Interview

December 2020

Sky Radio Live Interview

December 2020

Big City Radio Live

December 2020

BBC Essex Live Interview

December 2020

Radio News Hub Live

December 2020


RMDM Group in the News


Downloads


PanTum Detect is available at the following locations

CHHP London
76 Harley Street
London
W1G 7HH

Telephone: 020 7637 7677

 


 

Media Newsletter

Media related enquiries

For all enquiries please use the contact form below.